Clinical Trials Testing for Second Ohio State Cancer Drug
June 21, 2010 (Research Reports) - For the second time within a year, an experimental drug invented by cancer researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) is being tested on patients in a clinical trial. This week, adult patients began receiving doses of the potentially groundbreaking drug, which is designed to treat relapsed or treatment-resistant multiple myeloma, chronic lymphocytic leukemia or lymphoma. Read more. Support for the study was provided by The Leukemia and Lymphoma Society.
The Leukemia & Lymphoma SocietyŽ (LLS) is the world's largest voluntary health
agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma,
Hodgkin's disease and myeloma, and improve the quality of life of patients
and their families. LLS funds lifesaving blood cancer research around the
world and provides free information and support services.
Need Help? Contact us by email,
mail,
or call (800) 955-4572
print page
email this page
